Breaking News

Arcutis Biotherapeutics (NASDAQ: ARQT) has been garnering attention from analysts in recent months, with a noticeable uptick in price targets....

After analyzing the opinions of 7 analysts, Arvinas (NASDAQ: ARVN) has received a mix of ratings ranging from bullish to...

Deepwater Asset Management's managing partner, Gene Munster, was taken aback and disheartened by Apple's surprising choice to scrap its electric...

Microsoft's Copilot AI chatbot has once again caught users by surprise with a mysterious alter ego named "Sydney," who has...

Wedbush analyst Laura Chico has once again backed Denali Therapeutics (NASDAQ: DNLI) with an Outperform rating and a $31 price...

On February 28, 2024, Francois Brisebois, an analyst at Oppenheimer, once again expressed confidence in Tarsus Pharmaceuticals, giving it an...

Novavax, a leading player in the field of COVID-19 vaccines, has recently implemented major changes to its operations and finances....

Holley is projecting net sales of $150-160 million for the first quarter of 2024, down from an estimated $178.89 million....

Lindblad Expeditions Holdings, Inc. is anticipating tour revenues for the fiscal year 2024 to fall within the range of $610...

APi Group has revealed its anticipated sales forecast for the first quarter of 2024, projecting net revenues to fall within...